Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for receptor 2
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
Most Relevant Literature
- Heterogeneous expression and role of receptor tyrosine kinase-like orphan receptor 2 (ROR2) in small…
- KSK-74: Dual Histamine H3 and Sigma-2 Receptor Ligand with Anti-Obesity Potential.
- Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic fo…
- Novel agonist and antagonist radioligands for the GLP-2 receptor. Useful tools for studies of basic …
- A novel variant in the ROR2 gene underlying brachydactyly type B: a case report.
Most Relevant Clinical Trials
- Ocular Changes With Alpha-2 Receptor Agonist.
- Mineralocorticoid Receptor Antagonists in Type 2 Diabetes
- Melatonin, Soluble Urokinase-type Plasminogen Activator Receptor, and Orosomucoid 2 Levels in PPROM
- Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Rece…
- Protease Activated Receptor-2 and Gastrointestinal Dysfunction in Critical Illness
